H2 TEXT FOR SEARCH ENGINES
Today's Most Advanced Approaches for Identifying and Reversing Patients' Cardiovascular Disease
Boston Heart’s novel approach provides you with new diagnostic insights that inform medication and treatment selection and drive personalized lifestyle management programs for your high risk and secondary risk cardiovascular disease (CVD) patients.
Beyond our advanced testing, we have created breakthrough patient reports that improve health literacy and our scientifically-designed nutrition and lifestyle management programs are supported by our team of registered dietitians accessible to your patients by phone.
Together, we are improving the way that your patients engage and adhere to your treatment plans. Our innovative and integrated approach is designed to lead to better health literacy, medication adherence and management of your at-risk and CVD patients.
Boston Heart’s reports go far beyond reporting results. Our reports also offer interpretations that can help you with your diagnosis and treatment decisions.
Our lab results, interpretations and considerations are presented in an easy-to-read format. We offer succinct clinical treatment considerations to help you streamline patient care and communicate more effectively with your patients.
When you order testing from Boston Heart, we also provide you with a personalized patient Diagnostic Report to help you inspire your patients to engage differently with their heart health.
Cardiovascular disease is complex and every patient’s story is different. Partnering with you to address high risk and secondary risk prevention through our individualized reports and integrated lifestyle program has the power to engage your patients differently and change the way you and your patients communicate about disease to improve heart health.
Our Diagnostic Report is a breakthrough communication tool for you to use with your patients—helping to increase your patient’s understanding of their heart health and adherence to your treatment plans. Each patient’s story is told in the four parts of heart disease testing—Lipids, Inflammation, Metabolics and Genetics—and a Plan for Well Being with considerations for medications, supplements and lifestyle (including a personalized nutrition snapshot). This Plan for Well Being is an introduction for the patient to the Boston Heart Lifestyle Program.
Medication cannot cure CVD. However, patient lifestyle improvements, particularly in the areas of diet and exercise, are proven to benefit heart health and can help to reverse CVD and diabetes.
The Boston Heart Lifestyle Program integrates the results of a patient’s advanced testing and CVD risk assessment from our full menu of testing—lipids, inflammation, metabolics, genetics—with science-based recommendations for diet, exercise and other lifestyle modifications. The patient pursues these personally meaningful goals with the help of a coach—a Registered Dietitian who blends information and motivation to drive success. Additional resources in this program help you monitor each patient's progress.
Our approach draws on a foundation of peer reviewed clinical research and original dietary studies by nationally renowned nutrition, weight loss and diabetes-reversal experts Dr. Michael Dansinger, MD; Ernst Schaefer, MD; and Joi Gleason, MS, RD, LDN. We combine this knowledge with national nutrition guidelines for managing cholesterol and blood pressure, to create a highly effective solution.
When you advise your patients to enroll in our Lifestyle Program, we generate a personalized Life Plan, derived from a unique algorithm that provides a scientifically-designed eating strategy for each patient to reduce his or her CVD risk. The plan combines individual test results and risk factors with evidence-based dietary modifications that are personalized to their preferences, and will help your patients experience progress and stay motivated.
Lifestyle coaching is a key element of this program. Boston Heart's trained team of Registered Dietitians supports your patients with lifestyle coaching by phone. This dynamic, one-on-one personal connection has been shown to make long-term lifestyle changes more achievable.
Our Lifestyle Program supports your follow-up care with tools specifically designed to help you engage your patients—so that you can improve their health outcomes. The program is integrated with easy-to-use tools, including an online and smartphone accessible food and exercise tracker and motivational tips from coaches, to help your patients stay on track and in sync with your treatment guidance.
1. Myers, J. Exercise and Cardiovascular Health. Circulation. 2003;107: e2–e5.
2. Cannon CP, Braunwald E, McCabe CH, et al; for The Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495–1504.
3. LaRosa JC, Grundy SM, Waters DD, et al; for the Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425–1435.
4. Pedersen TR, Faergeman O, Kastelein JJP, et al; for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL Study: A randomized controlled trial. JAMA. 2005;294:2437–2445.
5. Roger VL, Go AS, Lloyd-Jones DM, et al; for The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics —2011 Update: A Report from the American Heart Association. Circulation. 2011;123:e18–e209.
- Learn more with Boston Heart videos.
- Did you know?
- A sedentary lifestyle is one of the five major risk factors for cardiovascular disease (along with high blood pressure, abnormal values for blood lipids, smoking, and obesity), as outlined by the AHA.1
- Recent research shows that following current cholesterol treatment guidelines reduces a patient’s risk for cardiovascular events by only 25%--this means standard therapy fails to address 75% of a patient’s residual risk for CVD events.2,3,4
- CVD claims more lives each year than cancer, chronic lower respiratory disease and accidents combined.5
- Test Menu
- For a complete listing and description of tests performed in our laboratory, see our Test Menu.